Press Release
Crypto.ro Expands to Spanish and French, Enhancing Global Reach With New Features and Strategic Partnerships
As part of its strategic growth, one of the companies owned by NUMERIS Corp., Crypto.ro, is expanding into Spanish and French, enhancing its global presence and accessibility. Read More
Press Release
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetes Designed to be simpler and more affordable to expand access to diabetes technology for previously underserved communities Commercial availability expected in early 2025 Read More
Press Release
Aloha Browser Offers Open Standard to Eliminate 'Annoying Cookie Banners' While Protecting User Privacy
The company rallies industry to adopt "One and Done" solution that enhances the effectiveness of current consent management practices while ensuring compliance with GDPR and other privacy regulations. Read More
Press Release
White-Glove Fertility Concierge & Surrogacy – Distinctive Approach Recognized by Beverly Hills Enclave
CEO Michelle Tang awarded Beverly Hills Living Magazine's Innovator of the Year - honoring her remarkable vision & creative approach to boutique fertility and surrogacy services. Situated in the heart of Beverly Hills, IMA ART has unceasingly provided bespoke advisory services, delivering an unparalleled experience for discerning individuals looking to build their families. Read More
Press Release
Caf2Code Expands Offerings by Adding Dynamics 365 Customer Engagement (CE) Apps to Portfolio
Microsoft Solutions Partner Caf2Code, leveraging its proven track record of client success, now offers Dynamics 365 Customer Engagement solutions designed to streamline customer relationship management (CRM) processes and accelerate business growth. Read More
Press Release
New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Click here to view interview video Paramount near-term activities include planned October 2024 commercial launch of FDA-approved oral mucositis prescription product Gelclair® and results from independent, investigator-initiated trials of crofelemer for rare diseases Read More
Press Release
